Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Parkinson Disease l: Introduction

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Alterations in Muscle Tone lll

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Glial Cell and Perineuronal Net Interactions in the Dorsal Striatum of Aged Mice.

Journal of experimental neurology·2026

Same author

Microglia-derived extracellular vesicles attenuate acute a-synuclein induced astrocyte inflammation.

bioRxiv : the preprint server for biology·2026

Same author

Glial cell and perineuronal net interactions in the dorsal striatum of aged mice.

bioRxiv : the preprint server for biology·2026

Same author

Parkinson's disease with and without history of Agent Orange exposure: A prospective study of US Veterans.

Parkinsonism & related disorders·2026

Same author

CDS-PD: a novel clinical decision support platform for Parkinson's disease.

Scientific reports·2026

Same author

Age-related inflammatory changes and perineuronal net dynamics: implications for aging.

Journal of neuroinflammation·2025

Search research articles

Related Experiment Video

Updated: May 16, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Parkinson's disease.

Timothy R Mhyre¹, James T Boyd, Robert W Hamill

¹Department of Neuroscience, Georgetown University Medical Center, 3970 Reservoir Road, NW NRB WP-24A, 20057, Washington, DC, USA, trm36@georgetown.edu.

Sub-Cellular Biochemistry

|December 11, 2012

Summary

This summary is machine-generated.

Parkinson's disease (PD) is a neurodegenerative disorder characterized by dopamine loss. Misfolded alpha-synuclein protein aggregates are central to PD pathology, driving disease progression and symptoms.

More Related Videos

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Related Experiment Videos

Last Updated: May 16, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

Area of Science:

Neuroscience
Neurology
Pathology

Background:

Parkinson's disease (PD) is a common age-related neurodegenerative disorder, historically known as 'Shaking Palsy'.
Dopamine deficiency underlies motor symptoms, and while replacement therapies offer symptomatic relief, they do not halt disease progression.
Understanding PD's complex etiology, pathology, and clinical manifestations beyond the dopaminergic system is crucial.

Purpose of the Study:

To review the current understanding of Parkinson's disease etiology and pathology.
To emphasize the role of misfolded alpha-synuclein in the disease process.
To discuss clinical symptoms and therapeutic strategies for PD.

Main Methods:

Review of existing literature on Parkinson's disease.
Analysis of clinical, pathological, and genetic studies.
Focus on the role of alpha-synuclein aggregation.

Main Results:

Parkinson's disease is a multifaceted disorder affecting multiple brain regions, not solely the dopamine system.
Intracytoplasmic inclusions containing alpha-synuclein are a hallmark of PD.
Aggregated, misfolded alpha-synuclein (a synucleinopathy) is implicated as a key pathological driver.

Conclusions:

Misfolded alpha-synuclein aggregates are central to Parkinson's disease pathology.
PD is a cerebral amyloid disease and the most common synucleinopathy.
Further research into alpha-synuclein is vital for developing effective PD therapies.